Ibuxin (Ibuprofen)

Ibuxin (ibuprofen) acts on the cyclooxygenase pathway to alleviate symptoms associated with various painful and inflammatory conditions.

• Pain relief: reduces mild to moderate pain such as dental, postoperative or injury‑related discomfort.
• Fever reduction: lowers elevated body temperature in febrile states.
• Inflammation reduction: diminishes swelling and redness in inflammatory processes.
• Headache: alleviates tension‑type and migraine‑associated headache.
• Musculoskeletal pain: eases pain from strains, sprains and arthritic conditions.
• Dysmenorrhea: relieves menstrual cramps and associated discomfort.

• Ibuxin works by reversibly inhibiting both cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which blocks the conversion of arachidonic acid to prostaglandins. The resulting decrease in prostaglandin synthesis reduces inflammation, lowers fever, and diminishes pain signaling at peripheral nerve endings, providing its therapeutic effects.

Ibuxin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Gastrointestinal discomfort (nausea, dyspepsia)
• Headache
• Dizziness
• Rash or mild skin irritation
• Mild elevation of liver enzymes
• Fluid retention or mild edema

Serious or Rare Side Effects

• Gastrointestinal bleeding or ulceration
• Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome)
• Renal impairment or acute kidney injury
• Hepatotoxicity with marked liver enzyme rise
• Cardiovascular thrombotic events (myocardial infarction, stroke)
• Blood dyscrasias such as agranulocytosis or aplastic anemia

When using Ibuxin, several precautionary measures should be observed to minimize risk.

• Assess renal and hepatic function before initiating therapy: baseline labs help detect pre‑existing impairment.
• Use the lowest effective dose for the shortest duration required to achieve therapeutic goals.
• Avoid use in patients with active peptic ulcer disease or a history of gastrointestinal bleeding.
• Monitor for signs of bleeding, especially in elderly patients or those on anticoagulants.
• Exercise caution in patients concurrently taking other NSAIDs, aspirin, or anticoagulant agents.
• Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture.

Ibuxin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Concurrent use with other NSAIDs or aspirin increases risk of gastrointestinal bleeding.
• Combination with anticoagulants (warfarin, direct oral anticoagulants) heightens bleeding potential.
• Co‑administration with selective serotonin reuptake inhibitors may raise bleeding tendency.
• Use with ACE inhibitors or diuretics may impair renal function.
• Concomitant lithium therapy can increase lithium serum concentrations.

Moderate Interactions (Monitor Closely)

• Interaction with methotrexate may increase its toxicity.
• Use with corticosteroids raises the risk of gastric ulceration.
• Co‑administration with antihypertensive agents may reduce their blood‑pressure‑lowering effect.
• Certain antidiabetic medications may have altered glucose control.
• Use with digoxin may increase serum digoxin levels, requiring monitoring.